nodes	percent_of_prediction	percent_of_DWPC	metapath
Nevirapine—Congenital anomaly—Tiludronate—Paget's disease of bone	0.0703	0.0703	CcSEcCtD
Nevirapine—Developmental delay—Tiludronate—Paget's disease of bone	0.0703	0.0703	CcSEcCtD
Nevirapine—Oral disorder—Etidronic acid—Paget's disease of bone	0.0506	0.0506	CcSEcCtD
Nevirapine—Oral disorder—Alendronate—Paget's disease of bone	0.0432	0.0432	CcSEcCtD
Nevirapine—Oral disorder—Pamidronate—Paget's disease of bone	0.0329	0.0329	CcSEcCtD
Nevirapine—Oral disorder—Zoledronate—Paget's disease of bone	0.0301	0.0301	CcSEcCtD
Nevirapine—Transaminases increased—Alendronate—Paget's disease of bone	0.0179	0.0179	CcSEcCtD
Nevirapine—Drug interaction—Alendronate—Paget's disease of bone	0.0118	0.0118	CcSEcCtD
Nevirapine—Rash maculo-papular—Etidronic acid—Paget's disease of bone	0.0116	0.0116	CcSEcCtD
Nevirapine—Ulcer—Alendronate—Paget's disease of bone	0.0115	0.0115	CcSEcCtD
Nevirapine—Myalgia—Tiludronate—Paget's disease of bone	0.00994	0.00994	CcSEcCtD
Nevirapine—Arthralgia—Tiludronate—Paget's disease of bone	0.00994	0.00994	CcSEcCtD
Nevirapine—Bone disorder—Risedronate—Paget's disease of bone	0.00969	0.00969	CcSEcCtD
Nevirapine—Hypercholesterolaemia—Risedronate—Paget's disease of bone	0.00925	0.00925	CcSEcCtD
Nevirapine—Ulcer—Risedronate—Paget's disease of bone	0.00925	0.00925	CcSEcCtD
Nevirapine—Inflammation—Risedronate—Paget's disease of bone	0.00902	0.00902	CcSEcCtD
Nevirapine—Musculoskeletal discomfort—Tiludronate—Paget's disease of bone	0.00868	0.00868	CcSEcCtD
Nevirapine—Inflammation—Pamidronate—Paget's disease of bone	0.00857	0.00857	CcSEcCtD
Nevirapine—Bone disorder—Zoledronate—Paget's disease of bone	0.00841	0.00841	CcSEcCtD
Nevirapine—Pain—Tiludronate—Paget's disease of bone	0.00815	0.00815	CcSEcCtD
Nevirapine—Inflammation—Zoledronate—Paget's disease of bone	0.00783	0.00783	CcSEcCtD
Nevirapine—Gastrointestinal pain—Tiludronate—Paget's disease of bone	0.00779	0.00779	CcSEcCtD
Nevirapine—Abdominal pain—Tiludronate—Paget's disease of bone	0.00754	0.00754	CcSEcCtD
Nevirapine—Toxic epidermal necrolysis—Alendronate—Paget's disease of bone	0.00713	0.00713	CcSEcCtD
Nevirapine—Stevens-Johnson syndrome—Etidronic acid—Paget's disease of bone	0.0071	0.0071	CcSEcCtD
Nevirapine—Neuropathy peripheral—Etidronic acid—Paget's disease of bone	0.00702	0.00702	CcSEcCtD
Nevirapine—Asthenia—Tiludronate—Paget's disease of bone	0.00684	0.00684	CcSEcCtD
Nevirapine—Agranulocytosis—Etidronic acid—Paget's disease of bone	0.00668	0.00668	CcSEcCtD
Nevirapine—Diarrhoea—Tiludronate—Paget's disease of bone	0.00652	0.00652	CcSEcCtD
Nevirapine—Erythema multiforme—Etidronic acid—Paget's disease of bone	0.00608	0.00608	CcSEcCtD
Nevirapine—Stevens-Johnson syndrome—Alendronate—Paget's disease of bone	0.00605	0.00605	CcSEcCtD
Nevirapine—Headache—Tiludronate—Paget's disease of bone	0.00597	0.00597	CcSEcCtD
Nevirapine—Liver function test abnormal—Risedronate—Paget's disease of bone	0.00586	0.00586	CcSEcCtD
Nevirapine—Nausea—Tiludronate—Paget's disease of bone	0.00566	0.00566	CcSEcCtD
Nevirapine—Erythema—Etidronic acid—Paget's disease of bone	0.00559	0.00559	CcSEcCtD
Nevirapine—Liver function test abnormal—Pamidronate—Paget's disease of bone	0.00557	0.00557	CcSEcCtD
Nevirapine—Erythema multiforme—Alendronate—Paget's disease of bone	0.00518	0.00518	CcSEcCtD
Nevirapine—Anaemia—Etidronic acid—Paget's disease of bone	0.00517	0.00517	CcSEcCtD
Nevirapine—Angioedema—Etidronic acid—Paget's disease of bone	0.00511	0.00511	CcSEcCtD
Nevirapine—Neutropenia—Pamidronate—Paget's disease of bone	0.00488	0.00488	CcSEcCtD
Nevirapine—Erythema—Alendronate—Paget's disease of bone	0.00477	0.00477	CcSEcCtD
Nevirapine—Arthralgia—Etidronic acid—Paget's disease of bone	0.00476	0.00476	CcSEcCtD
Nevirapine—Conjunctivitis—Risedronate—Paget's disease of bone	0.00476	0.00476	CcSEcCtD
Nevirapine—Discomfort—Etidronic acid—Paget's disease of bone	0.0047	0.0047	CcSEcCtD
Nevirapine—Hepatobiliary disease—Risedronate—Paget's disease of bone	0.00463	0.00463	CcSEcCtD
Nevirapine—Renal failure—Pamidronate—Paget's disease of bone	0.00457	0.00457	CcSEcCtD
Nevirapine—Conjunctivitis—Pamidronate—Paget's disease of bone	0.00452	0.00452	CcSEcCtD
Nevirapine—Neutropenia—Zoledronate—Paget's disease of bone	0.00446	0.00446	CcSEcCtD
Nevirapine—Ill-defined disorder—Alendronate—Paget's disease of bone	0.00442	0.00442	CcSEcCtD
Nevirapine—Anaemia—Alendronate—Paget's disease of bone	0.00441	0.00441	CcSEcCtD
Nevirapine—Angioedema—Alendronate—Paget's disease of bone	0.00435	0.00435	CcSEcCtD
Nevirapine—Agranulocytosis—Pamidronate—Paget's disease of bone	0.00434	0.00434	CcSEcCtD
Nevirapine—Connective tissue disorder—Risedronate—Paget's disease of bone	0.00432	0.00432	CcSEcCtD
Nevirapine—Malaise—Alendronate—Paget's disease of bone	0.0043	0.0043	CcSEcCtD
Nevirapine—Renal failure—Zoledronate—Paget's disease of bone	0.00418	0.00418	CcSEcCtD
Nevirapine—Musculoskeletal discomfort—Etidronic acid—Paget's disease of bone	0.00416	0.00416	CcSEcCtD
Nevirapine—Conjunctivitis—Zoledronate—Paget's disease of bone	0.00413	0.00413	CcSEcCtD
Nevirapine—Connective tissue disorder—Pamidronate—Paget's disease of bone	0.0041	0.0041	CcSEcCtD
Nevirapine—Paraesthesia—Etidronic acid—Paget's disease of bone	0.0041	0.0041	CcSEcCtD
Nevirapine—Myalgia—Alendronate—Paget's disease of bone	0.00406	0.00406	CcSEcCtD
Nevirapine—Discomfort—Alendronate—Paget's disease of bone	0.00401	0.00401	CcSEcCtD
Nevirapine—Immune system disorder—Risedronate—Paget's disease of bone	0.00397	0.00397	CcSEcCtD
Nevirapine—Agranulocytosis—Zoledronate—Paget's disease of bone	0.00397	0.00397	CcSEcCtD
Nevirapine—Immune system disorder—Pamidronate—Paget's disease of bone	0.00377	0.00377	CcSEcCtD
Nevirapine—Feeling abnormal—Etidronic acid—Paget's disease of bone	0.00376	0.00376	CcSEcCtD
Nevirapine—Connective tissue disorder—Zoledronate—Paget's disease of bone	0.00375	0.00375	CcSEcCtD
Nevirapine—Gastrointestinal pain—Etidronic acid—Paget's disease of bone	0.00373	0.00373	CcSEcCtD
Nevirapine—Erythema—Pamidronate—Paget's disease of bone	0.00364	0.00364	CcSEcCtD
Nevirapine—Urticaria—Etidronic acid—Paget's disease of bone	0.00363	0.00363	CcSEcCtD
Nevirapine—Abdominal pain—Etidronic acid—Paget's disease of bone	0.00361	0.00361	CcSEcCtD
Nevirapine—Musculoskeletal discomfort—Alendronate—Paget's disease of bone	0.00354	0.00354	CcSEcCtD
Nevirapine—Anaemia—Risedronate—Paget's disease of bone	0.00353	0.00353	CcSEcCtD
Nevirapine—Angioedema—Risedronate—Paget's disease of bone	0.00349	0.00349	CcSEcCtD
Nevirapine—Immune system disorder—Zoledronate—Paget's disease of bone	0.00345	0.00345	CcSEcCtD
Nevirapine—Ill-defined disorder—Pamidronate—Paget's disease of bone	0.00337	0.00337	CcSEcCtD
Nevirapine—Hypersensitivity—Etidronic acid—Paget's disease of bone	0.00336	0.00336	CcSEcCtD
Nevirapine—Anaemia—Pamidronate—Paget's disease of bone	0.00336	0.00336	CcSEcCtD
Nevirapine—Pain—Alendronate—Paget's disease of bone	0.00333	0.00333	CcSEcCtD
Nevirapine—Angioedema—Pamidronate—Paget's disease of bone	0.00332	0.00332	CcSEcCtD
Nevirapine—Erythema—Zoledronate—Paget's disease of bone	0.00332	0.00332	CcSEcCtD
Nevirapine—Malaise—Pamidronate—Paget's disease of bone	0.00328	0.00328	CcSEcCtD
Nevirapine—Myalgia—Risedronate—Paget's disease of bone	0.00326	0.00326	CcSEcCtD
Nevirapine—Arthralgia—Risedronate—Paget's disease of bone	0.00326	0.00326	CcSEcCtD
Nevirapine—Unspecified disorder of skin and subcutaneous tissue—Risedronate—Paget's disease of bone	0.00323	0.00323	CcSEcCtD
Nevirapine—Pruritus—Etidronic acid—Paget's disease of bone	0.00323	0.00323	CcSEcCtD
Nevirapine—Feeling abnormal—Alendronate—Paget's disease of bone	0.00321	0.00321	CcSEcCtD
Nevirapine—Gastrointestinal pain—Alendronate—Paget's disease of bone	0.00318	0.00318	CcSEcCtD
Nevirapine—Diarrhoea—Etidronic acid—Paget's disease of bone	0.00312	0.00312	CcSEcCtD
Nevirapine—Arthralgia—Pamidronate—Paget's disease of bone	0.00309	0.00309	CcSEcCtD
Nevirapine—Myalgia—Pamidronate—Paget's disease of bone	0.00309	0.00309	CcSEcCtD
Nevirapine—Urticaria—Alendronate—Paget's disease of bone	0.00309	0.00309	CcSEcCtD
Nevirapine—Ill-defined disorder—Zoledronate—Paget's disease of bone	0.00308	0.00308	CcSEcCtD
Nevirapine—Body temperature increased—Alendronate—Paget's disease of bone	0.00307	0.00307	CcSEcCtD
Nevirapine—Abdominal pain—Alendronate—Paget's disease of bone	0.00307	0.00307	CcSEcCtD
Nevirapine—Anaemia—Zoledronate—Paget's disease of bone	0.00307	0.00307	CcSEcCtD
Nevirapine—Nervous system disorder—Risedronate—Paget's disease of bone	0.00306	0.00306	CcSEcCtD
Nevirapine—Discomfort—Pamidronate—Paget's disease of bone	0.00306	0.00306	CcSEcCtD
Nevirapine—Angioedema—Zoledronate—Paget's disease of bone	0.00303	0.00303	CcSEcCtD
Nevirapine—Skin disorder—Risedronate—Paget's disease of bone	0.00303	0.00303	CcSEcCtD
Nevirapine—Malaise—Zoledronate—Paget's disease of bone	0.00299	0.00299	CcSEcCtD
Nevirapine—Oedema—Pamidronate—Paget's disease of bone	0.00297	0.00297	CcSEcCtD
Nevirapine—Anaphylactic shock—Pamidronate—Paget's disease of bone	0.00297	0.00297	CcSEcCtD
Nevirapine—Nervous system disorder—Pamidronate—Paget's disease of bone	0.00291	0.00291	CcSEcCtD
Nevirapine—Thrombocytopenia—Pamidronate—Paget's disease of bone	0.0029	0.0029	CcSEcCtD
Nevirapine—Vomiting—Etidronic acid—Paget's disease of bone	0.0029	0.0029	CcSEcCtD
Nevirapine—Rash—Etidronic acid—Paget's disease of bone	0.00288	0.00288	CcSEcCtD
Nevirapine—Dermatitis—Etidronic acid—Paget's disease of bone	0.00288	0.00288	CcSEcCtD
Nevirapine—Hypersensitivity—Alendronate—Paget's disease of bone	0.00287	0.00287	CcSEcCtD
Nevirapine—Headache—Etidronic acid—Paget's disease of bone	0.00286	0.00286	CcSEcCtD
Nevirapine—Musculoskeletal discomfort—Risedronate—Paget's disease of bone	0.00284	0.00284	CcSEcCtD
Nevirapine—Anorexia—Pamidronate—Paget's disease of bone	0.00283	0.00283	CcSEcCtD
Nevirapine—Arthralgia—Zoledronate—Paget's disease of bone	0.00283	0.00283	CcSEcCtD
Nevirapine—Myalgia—Zoledronate—Paget's disease of bone	0.00283	0.00283	CcSEcCtD
Nevirapine—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—Paget's disease of bone	0.00281	0.00281	CcSEcCtD
Nevirapine—Paraesthesia—Risedronate—Paget's disease of bone	0.0028	0.0028	CcSEcCtD
Nevirapine—Discomfort—Zoledronate—Paget's disease of bone	0.00279	0.00279	CcSEcCtD
Nevirapine—Asthenia—Alendronate—Paget's disease of bone	0.00279	0.00279	CcSEcCtD
Nevirapine—Pruritus—Alendronate—Paget's disease of bone	0.00275	0.00275	CcSEcCtD
Nevirapine—Nausea—Etidronic acid—Paget's disease of bone	0.00271	0.00271	CcSEcCtD
Nevirapine—Oedema—Zoledronate—Paget's disease of bone	0.00271	0.00271	CcSEcCtD
Nevirapine—Anaphylactic shock—Zoledronate—Paget's disease of bone	0.00271	0.00271	CcSEcCtD
Nevirapine—Musculoskeletal discomfort—Pamidronate—Paget's disease of bone	0.0027	0.0027	CcSEcCtD
Nevirapine—Gastrointestinal disorder—Risedronate—Paget's disease of bone	0.00269	0.00269	CcSEcCtD
Nevirapine—Fatigue—Risedronate—Paget's disease of bone	0.00269	0.00269	CcSEcCtD
Nevirapine—Pain—Risedronate—Paget's disease of bone	0.00267	0.00267	CcSEcCtD
Nevirapine—Paraesthesia—Pamidronate—Paget's disease of bone	0.00266	0.00266	CcSEcCtD
Nevirapine—Diarrhoea—Alendronate—Paget's disease of bone	0.00266	0.00266	CcSEcCtD
Nevirapine—Nervous system disorder—Zoledronate—Paget's disease of bone	0.00266	0.00266	CcSEcCtD
Nevirapine—Thrombocytopenia—Zoledronate—Paget's disease of bone	0.00265	0.00265	CcSEcCtD
Nevirapine—Somnolence—Pamidronate—Paget's disease of bone	0.00264	0.00264	CcSEcCtD
Nevirapine—Skin disorder—Zoledronate—Paget's disease of bone	0.00263	0.00263	CcSEcCtD
Nevirapine—Anorexia—Zoledronate—Paget's disease of bone	0.00258	0.00258	CcSEcCtD
Nevirapine—Decreased appetite—Pamidronate—Paget's disease of bone	0.00258	0.00258	CcSEcCtD
Nevirapine—Gastrointestinal disorder—Pamidronate—Paget's disease of bone	0.00256	0.00256	CcSEcCtD
Nevirapine—Fatigue—Pamidronate—Paget's disease of bone	0.00256	0.00256	CcSEcCtD
Nevirapine—Gastrointestinal pain—Risedronate—Paget's disease of bone	0.00255	0.00255	CcSEcCtD
Nevirapine—Pain—Pamidronate—Paget's disease of bone	0.00254	0.00254	CcSEcCtD
Nevirapine—Urticaria—Risedronate—Paget's disease of bone	0.00248	0.00248	CcSEcCtD
Nevirapine—Vomiting—Alendronate—Paget's disease of bone	0.00247	0.00247	CcSEcCtD
Nevirapine—Musculoskeletal discomfort—Zoledronate—Paget's disease of bone	0.00247	0.00247	CcSEcCtD
Nevirapine—Body temperature increased—Risedronate—Paget's disease of bone	0.00247	0.00247	CcSEcCtD
Nevirapine—Abdominal pain—Risedronate—Paget's disease of bone	0.00247	0.00247	CcSEcCtD
Nevirapine—Rash—Alendronate—Paget's disease of bone	0.00245	0.00245	CcSEcCtD
Nevirapine—Dermatitis—Alendronate—Paget's disease of bone	0.00245	0.00245	CcSEcCtD
Nevirapine—Feeling abnormal—Pamidronate—Paget's disease of bone	0.00244	0.00244	CcSEcCtD
Nevirapine—Headache—Alendronate—Paget's disease of bone	0.00244	0.00244	CcSEcCtD
Nevirapine—Paraesthesia—Zoledronate—Paget's disease of bone	0.00243	0.00243	CcSEcCtD
Nevirapine—Gastrointestinal pain—Pamidronate—Paget's disease of bone	0.00243	0.00243	CcSEcCtD
Nevirapine—Somnolence—Zoledronate—Paget's disease of bone	0.00241	0.00241	CcSEcCtD
Nevirapine—Decreased appetite—Zoledronate—Paget's disease of bone	0.00236	0.00236	CcSEcCtD
Nevirapine—Body temperature increased—Pamidronate—Paget's disease of bone	0.00235	0.00235	CcSEcCtD
Nevirapine—Abdominal pain—Pamidronate—Paget's disease of bone	0.00235	0.00235	CcSEcCtD
Nevirapine—Gastrointestinal disorder—Zoledronate—Paget's disease of bone	0.00234	0.00234	CcSEcCtD
Nevirapine—Fatigue—Zoledronate—Paget's disease of bone	0.00234	0.00234	CcSEcCtD
Nevirapine—Pain—Zoledronate—Paget's disease of bone	0.00232	0.00232	CcSEcCtD
Nevirapine—Nausea—Alendronate—Paget's disease of bone	0.00231	0.00231	CcSEcCtD
Nevirapine—Hypersensitivity—Risedronate—Paget's disease of bone	0.0023	0.0023	CcSEcCtD
Nevirapine—Asthenia—Risedronate—Paget's disease of bone	0.00224	0.00224	CcSEcCtD
Nevirapine—Feeling abnormal—Zoledronate—Paget's disease of bone	0.00223	0.00223	CcSEcCtD
Nevirapine—Gastrointestinal pain—Zoledronate—Paget's disease of bone	0.00222	0.00222	CcSEcCtD
Nevirapine—Pruritus—Risedronate—Paget's disease of bone	0.00221	0.00221	CcSEcCtD
Nevirapine—Hypersensitivity—Pamidronate—Paget's disease of bone	0.00219	0.00219	CcSEcCtD
Nevirapine—Urticaria—Zoledronate—Paget's disease of bone	0.00215	0.00215	CcSEcCtD
Nevirapine—Body temperature increased—Zoledronate—Paget's disease of bone	0.00214	0.00214	CcSEcCtD
Nevirapine—Abdominal pain—Zoledronate—Paget's disease of bone	0.00214	0.00214	CcSEcCtD
Nevirapine—Diarrhoea—Risedronate—Paget's disease of bone	0.00214	0.00214	CcSEcCtD
Nevirapine—Asthenia—Pamidronate—Paget's disease of bone	0.00213	0.00213	CcSEcCtD
Nevirapine—Pruritus—Pamidronate—Paget's disease of bone	0.0021	0.0021	CcSEcCtD
Nevirapine—Diarrhoea—Pamidronate—Paget's disease of bone	0.00203	0.00203	CcSEcCtD
Nevirapine—Hypersensitivity—Zoledronate—Paget's disease of bone	0.002	0.002	CcSEcCtD
Nevirapine—Vomiting—Risedronate—Paget's disease of bone	0.00198	0.00198	CcSEcCtD
Nevirapine—Rash—Risedronate—Paget's disease of bone	0.00197	0.00197	CcSEcCtD
Nevirapine—Dermatitis—Risedronate—Paget's disease of bone	0.00197	0.00197	CcSEcCtD
Nevirapine—Headache—Risedronate—Paget's disease of bone	0.00196	0.00196	CcSEcCtD
Nevirapine—Asthenia—Zoledronate—Paget's disease of bone	0.00194	0.00194	CcSEcCtD
Nevirapine—Pruritus—Zoledronate—Paget's disease of bone	0.00192	0.00192	CcSEcCtD
Nevirapine—Vomiting—Pamidronate—Paget's disease of bone	0.00189	0.00189	CcSEcCtD
Nevirapine—Rash—Pamidronate—Paget's disease of bone	0.00187	0.00187	CcSEcCtD
Nevirapine—Dermatitis—Pamidronate—Paget's disease of bone	0.00187	0.00187	CcSEcCtD
Nevirapine—Headache—Pamidronate—Paget's disease of bone	0.00186	0.00186	CcSEcCtD
Nevirapine—Diarrhoea—Zoledronate—Paget's disease of bone	0.00185	0.00185	CcSEcCtD
Nevirapine—Nausea—Risedronate—Paget's disease of bone	0.00185	0.00185	CcSEcCtD
Nevirapine—Nausea—Pamidronate—Paget's disease of bone	0.00176	0.00176	CcSEcCtD
Nevirapine—Vomiting—Zoledronate—Paget's disease of bone	0.00172	0.00172	CcSEcCtD
Nevirapine—Rash—Zoledronate—Paget's disease of bone	0.00171	0.00171	CcSEcCtD
Nevirapine—Dermatitis—Zoledronate—Paget's disease of bone	0.00171	0.00171	CcSEcCtD
Nevirapine—Headache—Zoledronate—Paget's disease of bone	0.0017	0.0017	CcSEcCtD
Nevirapine—Nausea—Zoledronate—Paget's disease of bone	0.00161	0.00161	CcSEcCtD
